carbachol has been researched along with Cancer of Esophagus in 2 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sung, EZ | 1 |
| Arasaradnam, RP | 1 |
| Jarvie, EM | 1 |
| James, S | 1 |
| Goodyear, SJ | 1 |
| Borman, RA | 1 |
| Snead, D | 1 |
| Sanger, GJ | 1 |
| Nwokolo, CU | 1 |
| Sims, SM | 1 |
| Jiao, Y | 1 |
| Preiksaitis, HG | 1 |
2 other studies available for carbachol and Cancer of Esophagus
| Article | Year |
|---|---|
Effects of neo-adjuvant chemotherapy for oesophago-gastric cancer on neuro-muscular gastric function.
Topics: Acetylcholinesterase; Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecita | 2012 |
Regulation of intracellular calcium in human esophageal smooth muscles.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1997 |